The steerable needle market size is projected to be worth US$ 1.09 billion in 2023. The market is likely to surpass US$ 2.13 billion by 2033 at a CAGR of 6.9% during the forecast period. With the global population aging rapidly, there is an increased demand for effective diagnostic and treatment solutions for age-related conditions. Steerable needles are advanced medical devices designed to enhance the precision and accuracy of needle-based procedures, such as biopsies, ablations, and drug delivery.
Other Drivers Propelling the Demand for Steerable Needle Market include:
Challenges for Companies /Manufacturers in the Steerable Needle Market:
Opportunities in the Steerable Needle Industry:
Latest Trends in the Steerable Needle Market:
| Attributes | Details |
|---|---|
| Steerable Needle Market Size (2023) | US$ 1.09 billion |
| Steerable Needle Market Projected Size (2033) | US$ 2.13 billion |
| Value CAGR (2023 to 2033) | 6.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global steerable needle market experienced a CAGR of 5.7%, reaching a market size of US$ 1.09 billion in 2023.
Worldwide, there is a significant shift toward minimally invasive procedures. Steerable needles allow practitioners to perform precise and targeted interventions while causing minimum tissue damage, reducing patient discomfort, and allowing for shorter recovery times. As a result, demand for steerable needles is projected to rise as medical professionals seek to provide patients with minimally invasive alternatives.
Personalized medicine, in which therapies are tailored to specific patients, is gaining popularity. Steerable needles enable targeted drug delivery and precise interventions based on individual patient characteristics. The demand for steerable needles is projected to rise as personalized treatment becomes more common.
Future Forecast for Steerable Needle Industry:
Looking ahead, the global steerable needle market is expected to rise at a CAGR of 6.9% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.13 billion by 2033.
The steerable needle market is seeing growth opportunities in developing regions such as Asia-Pacific and Latin America. These regions are undergoing tremendous economic development, as well as improvements in healthcare infrastructure and increased investments in healthcare technologies. Steerable needles are predicted to become more popular in these markets as access to modern medical technologies improves.
Steerable needles are in demand due to technological improvements such as robotic-assisted steering mechanisms, real-time imaging guiding, and sensor-enabled navigation systems. These developments improve the precision, accuracy, and safety of needle-based operations, resulting in increased utilization by healthcare practitioners.
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 676.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The steerable needle market in the United States is expected to reach a market size of US$ 676.0 million by 2033, expanding at a CAGR of 7.0%. In the USA, the market expansion is fueled by factors such as the increasing adoption of minimally invasive procedures, a rising incidence of chronic diseases, advancements in needle technology, and a growing emphasis on personalized medicine. Also, the aging population and investments in healthcare infrastructure contribute to the market's growth.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 116.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The steerable needle market in the United Kingdom is expected to reach a market value of US$ 116.3 million, expanding at a CAGR of 7.2% during the forecast period. The market in the UK is expected to witness significant growth in the coming years. The UK's focus on healthcare advancements, investments in research and development, and the availability of advanced healthcare infrastructure contribute to the market's expansion. The market is poised to benefit from the increasing demand for precise and targeted interventions, driving the growth of the steerable needle market in the UK.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 147.8 million |
| CAGR % 2023 to End of Forecast (2033) | 7.6% |
The steerable needle market in China is anticipated to reach a market size of US$ 147.8 million by the end of 2033, growing at a CAGR of 7.6% throughout the forecast period. With rising income levels and increased awareness of advanced healthcare technologies, the demand for precise and targeted interventions is growing in China. Patients are seeking high-quality medical treatments, leading to increased adoption of steerable needles by healthcare providers to meet the rising demand.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 107.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.5% |
The steerable needle market in Japan is estimated to reach a market size of US$ 107.6 million by 2033, expected to thrive at a CAGR of 7.5%. Japan boasts a robust healthcare infrastructure, with well-equipped hospitals, research institutes, and skilled healthcare professionals. The presence of advanced healthcare facilities and a highly trained medical workforce supports the adoption of advanced medical devices like steerable needles. The strong healthcare infrastructure acts as a catalyst for market growth.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 121.9 million |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The steerable needle market in South Korea is expected to reach a market size of US$ 121.9 million, expanding at a CAGR of 7.2% during the forecast period. South Korea has witnessed an increasing preference for minimally invasive procedures across various medical specialties. Steerable needles are essential tools in performing precise and targeted interventions with minimal tissue disruption, reduced patient discomfort, and faster recovery times. The rising demand for minimally invasive procedures has led to an increased adoption of steerable needles in the country.
Principal Consultant
Based on products, bevel-tip flexible needles dominated the category withholding the significant share of the market at around 38.9% at the end of 2022. Bevel-tip flexible needles are designed with a flexible shaft that allows for greater maneuverability and navigation through complex anatomical structures.
Over time, surgeons have become accustomed to using bevel-tip flexible needles due to their widespread availability and advantages. Familiarity and positive experiences with these needles lead to their continued adoption in the field.
Based on application, biopsy segment has led the category withholding about 24.5% of the total market share. Steerable needles enable a minimally invasive approach to biopsies. Compared to traditional open surgical procedures, steerable needles can be inserted through small incisions or even percutaneously, resulting in less tissue trauma, reduced scarring, shorter recovery times, and lower risks of complications.
The hospitals have led the steerable needle market as the leading end user with the market share of 59.4% in 2022. Hospitals are full-service medical facilities that offer a wide range of medical services, including diagnostic tests. They have the infrastructure, technology, and competence to provide a wide range of diagnostic tests, treatments and services, which demands the need for needles, including steerable needles.
The steerable needle market has undergone market consolidation, with key players establishing and vying to maintain their competitive edge. Key players in the steerable needle industry are using certain strategies to stay competitive, such as differentiating their offerings, and adapting to evolving market dynamics. Continuous innovation, strong partnerships, regulatory compliance, and strategic market expansion.
Key Strategies Used by the Participants
Key players continuously invest in research and development to introduce innovative products. They strive to develop assays with improved sensitivity, specificity, accuracy, and ease of use.
Key players often form strategic partnerships and collaborations with other companies, research institutions, and healthcare organizations. These partnerships can lead to knowledge sharing, joint product development, and expanded market reach.
Expanding into emerging markets with growing healthcare infrastructure and rising demand for steerable needles allows companies to tap into new opportunities and gain a competitive edge.
Companies in the market may engage in mergers or acquisitions to streamline their product portfolio, obtain new technologies, enter new market niches, and gain access to novel products or intellectual property.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Steerable Needle Market:
The steerable needle market is expected to progress at 6.9% CAGR until 2033.
The overall steerable needle market is projected to reach around US$ 2.13 billion by 2033.
Bevel-tip flexible needles made up for 38.9% market revenue in 2022.
China dominates the Asia Pacific market and is projected to advance at 7.6% CAGR through 2033.
Application steerable needles in biopsy segment captured almost 24.5% market share in 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis, by Region 4.2. New Product Launches 4.3. Regulatory Landscape, by Country 4.4. PESTEL Analysis 4.5. Porter’s Five Force Analysis 4.6. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Surgical Needles Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Minimally Invasive Surgical Procedures 5.2.2. Advancements in Robotics and Image-Guided Systems 5.2.3. Increasing Incidence of Chronic Diseases 5.2.4. Technological Innovations and Product Development 5.2.5. Growing Healthcare Expenditure 5.2.6. Frequency of Product Approvals 5.2.7. Consumption Rate 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 6.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022 6.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 6.3.1. Y-o-Y Growth Trend Analysis 6.3.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By Product, 2017 to 2022 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2023 to 2033 7.3.1. Bevel-Tip Flexible Needles 7.3.2. Symmetric-Tip Needles 7.3.3. Tendonactuated Tips 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 8.3.1. Biopsy 8.3.2. Tumor Ablation 8.3.3. Pain Management 8.3.4. Neurosurgery 8.3.5. Cardiac Interventions 8.3.6. Interventional Radiology 8.3.7. Robotic-Assisted Procedures 8.4. Market Attractiveness Analysis By Application 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Specialty Clinics 9.4. Market Attractiveness Analysis By End User 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis, By Region, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. USA 11.3.1.2. Canada 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By Application 11.4.4. By End User 11.5. Market Trends 11.6. Market Drivers & Restraints – Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. USA Market 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast by Market Taxonomy 11.7.1.2.1. By Product 11.7.1.2.2. By Application 11.7.1.2.3. By End User 11.7.2. Canada Market 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast by Market Taxonomy 11.7.2.2.1. By Product 11.7.2.2.2. By Application 11.7.2.2.3. By End User 12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of LATAM 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By Application 12.4.4. By End User 12.5. Market Trends 12.6. Market Drivers & Restraints – Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Brazil Market 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Product 12.7.1.2.2. By Application 12.7.1.2.3. By End User 12.7.2. Mexico Market 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Product 12.7.2.2.2. By Application 12.7.2.2.3. By End User 12.7.3. Argentina Market 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast by Market Taxonomy 12.7.3.2.1. By Product 12.7.3.2.2. By Application 12.7.3.2.3. By End User 13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. UK 13.3.1.2. Germany 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Application 13.4.4. By End User 13.5. Market Trends 13.6. Market Drivers & Restraints – Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. UK Market 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Product 13.7.1.2.2. By Application 13.7.1.2.3. By End User 13.7.2. Germany Market 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Product 13.7.2.2.2. By Application 13.7.2.2.3. By End User 13.7.3. France Market 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Product 13.7.3.2.2. By Application 13.7.3.2.3. By End User 13.7.4. Italy Market 13.7.4.1. Introduction 13.7.4.2. Market Analysis and Forecast by Market Taxonomy 13.7.4.2.1. By Product 13.7.4.2.2. By Application 13.7.4.2.3. By End User 13.7.5. Spain Market 13.7.5.1. Introduction 13.7.5.2. Market Analysis and Forecast by Market Taxonomy 13.7.5.2.1. By Product 13.7.5.2.2. By Application 13.7.5.2.3. By End User 13.7.6. BENELUX Market 13.7.6.1. Introduction 13.7.6.2. Market Analysis and Forecast by Market Taxonomy 13.7.6.2.1. By Product 13.7.6.2.2. By Application 13.7.6.2.3. By End User 13.7.7. Russia Market 13.7.7.1. Introduction 13.7.7.2. Market Analysis and Forecast by Market Taxonomy 13.7.7.2.1. By Product 13.7.7.2.2. By Application 13.7.7.2.3. By End User 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Market Trends 14.6. Market Drivers & Restraints – Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. China Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By Application 14.7.1.2.3. By End User 14.7.2. Japan Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By Application 14.7.2.2.3. By End User 14.7.3. South Korea Market 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Product 14.7.3.2.2. By Application 14.7.3.2.3. By End User 15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Indonesia 15.3.1.3. Thailand 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Market Trends 15.6. Market Drivers & Restraints – Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. India Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By Application 15.7.1.2.3. By End User 15.7.2. Indonesia Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By Application 15.7.2.2.3. By End User 15.7.3. Thailand Market 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Product 15.7.3.2.2. By Application 15.7.3.2.3. By End User 15.7.4. Malaysia Market 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast by Market Taxonomy 15.7.4.2.1. By Product 15.7.4.2.2. By Application 15.7.4.2.3. By End User 16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Market Trends 16.6. Market Drivers & Restraints – Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. Australia Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Application 16.7.1.2.3. By End User 16.7.2. New Zealand Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Application 16.7.2.2.3. By End User 17. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Türkiye 17.3.1.3. South Africa 17.3.1.4. Northern Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Market Trends 17.6. Market Drivers & Restraints – Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. GCC Countries Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Application 17.7.1.2.3. By End User 17.7.2. Türkiye Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Application 17.7.2.2.3. By End User 17.7.3. South Africa Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Application 17.7.3.2.3. By End User 17.7.4. Northern Africa Market 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Product 17.7.4.2.2. By Application 17.7.4.2.3. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies (Maternity Care Products) 18.2. Market Share Analysis of Top Players 18.3. Market Concentration 19. Competition Analysis 19.1. Competition Dashboard 19.2. Branding and Promotional Strategies, By key Players 19.3. Key Development Analysis 19.4. Competition Deep Dive 19.4.1. AprioMed 19.4.1.1. Overview 19.4.1.2. Product Portfolio 19.4.1.3. Key Financials 19.4.1.4. SWOT Analysis 19.4.1.5. Key Developments 19.4.1.6. Sales Footprint 19.4.1.7. Strategy Overview 19.4.1.7.1. Marketing Strategy 19.4.1.7.2. Product Strategy 19.4.1.7.3. Channel Strategy 19.4.2. Elekta Instrument AB, 19.4.2.1. Overview 19.4.2.2. Product Portfolio 19.4.2.3. Key Financials 19.4.2.4. SWOT Analysis 19.4.2.5. Key Developments 19.4.2.6. Sales Footprint 19.4.2.7. Strategy Overview 19.4.2.7.1. Marketing Strategy 19.4.2.7.2. Product Strategy 19.4.2.7.3. Channel Strategy 19.4.3. Medtronic 19.4.3.1. Overview 19.4.3.2. Product Portfolio 19.4.3.3. Key Financials 19.4.3.4. SWOT Analysis 19.4.3.5. Key Developments 19.4.3.6. Sales Footprint 19.4.3.7. Strategy Overview 19.4.3.7.1. Marketing Strategy 19.4.3.7.2. Product Strategy 19.4.3.7.3. Channel Strategy 19.4.4. Boston Scientific 19.4.4.1. Overview 19.4.4.2. Product Portfolio 19.4.4.3. Key Financials 19.4.4.4. SWOT Analysis 19.4.4.5. Key Developments 19.4.4.6. Sales Footprint 19.4.4.7. Strategy Overview 19.4.4.7.1. Marketing Strategy 19.4.4.7.2. Product Strategy 19.4.4.7.3. Channel Strategy 19.4.5. Cook Medical 19.4.5.1. Overview 19.4.5.2. Product Portfolio 19.4.5.3. Key Financials 19.4.5.4. SWOT Analysis 19.4.5.5. Key Developments 19.4.5.6. Sales Footprint 19.4.5.7. Strategy Overview 19.4.5.7.1. Marketing Strategy 19.4.5.7.2. Product Strategy 19.4.5.7.3. Channel Strategy 19.4.6. Olympus Corporation 19.4.6.1. Overview 19.4.6.2. Product Portfolio 19.4.6.3. Key Financials 19.4.6.4. SWOT Analysis 19.4.6.5. Key Developments 19.4.6.6. Sales Footprint 19.4.6.7. Strategy Overview 19.4.6.7.1. Marketing Strategy 19.4.6.7.2. Product Strategy 19.4.6.7.3. Channel Strategy 19.4.7. Terumo Corporation 19.4.7.1. Overview 19.4.7.2. Product Portfolio 19.4.7.3. Key Financials 19.4.7.4. SWOT Analysis 19.4.7.5. Key Developments 19.4.7.6. Sales Footprint 19.4.7.7. Strategy Overview 19.4.7.7.1. Marketing Strategy 19.4.7.7.2. Product Strategy 19.4.7.7.3. Channel Strategy 19.4.8. Merit Medical Systems 19.4.8.1. Overview 19.4.8.2. Product Portfolio 19.4.8.3. Key Financials 19.4.8.4. SWOT Analysis 19.4.8.5. Key Developments 19.4.8.6. Sales Footprint 19.4.8.7. Strategy Overview 19.4.8.7.1. Marketing Strategy 19.4.8.7.2. Product Strategy 19.4.8.7.3. Channel Strategy 19.4.9. Vygon 19.4.9.1. Overview 19.4.9.2. Product Portfolio 19.4.9.3. Key Financials 19.4.9.4. SWOT Analysis 19.4.9.5. Key Developments 19.4.9.6. Sales Footprint 19.4.9.7. Strategy Overview 19.4.9.7.1. Marketing Strategy 19.4.9.7.2. Product Strategy 19.4.9.7.3. Channel Strategy 19.4.10. Johnson & Johnson 19.4.10.1. Overview 19.4.10.2. Product Portfolio 19.4.10.3. Key Financials 19.4.10.4. SWOT Analysis 19.4.10.5. Key Developments 19.4.10.6. Sales Footprint 19.4.10.7. Strategy Overview 19.4.10.7.1. Marketing Strategy 19.4.10.7.2. Product Strategy 19.4.10.7.3. Channel Strategy 19.4.11. B. Braun Melsungen AG 19.4.11.1. Overview 19.4.11.2. Product Portfolio 19.4.11.3. Key Financials 19.4.11.4. SWOT Analysis 19.4.11.5. Key Developments 19.4.11.6. Sales Footprint 19.4.11.7. Strategy Overview 19.4.11.7.1. Marketing Strategy 19.4.11.7.2. Product Strategy 19.4.11.7.3. Channel Strategy 19.4.12. Stryker Corporation 19.4.12.1. Overview 19.4.12.2. Product Portfolio 19.4.12.3. Key Financials 19.4.12.4. SWOT Analysis 19.4.12.5. Key Developments 19.4.12.6. Sales Footprint 19.4.12.7. Strategy Overview 19.4.12.7.1. Marketing Strategy 19.4.12.7.2. Product Strategy 19.4.12.7.3. Channel Strategy 19.4.13. Smith & Nephew 19.4.13.1. Overview 19.4.13.2. Product Portfolio 19.4.13.3. Key Financials 19.4.13.4. SWOT Analysis 19.4.13.5. Key Developments 19.4.13.6. Sales Footprint 19.4.13.7. Strategy Overview 19.4.13.7.1. Marketing Strategy 19.4.13.7.2. Product Strategy 19.4.13.7.3. Channel Strategy 19.4.14. AngioDynamics Inc. 19.4.14.1. Overview 19.4.14.2. Product Portfolio 19.4.14.3. Key Financials 19.4.14.4. SWOT Analysis 19.4.14.5. Key Developments 19.4.14.6. Sales Footprint 19.4.14.7. Strategy Overview 19.4.14.7.1. Marketing Strategy 19.4.14.7.2. Product Strategy 19.4.14.7.3. Channel Strategy 19.4.15. Teleflex Incorporated 19.4.15.1. Overview 19.4.15.2. Product Portfolio 19.4.15.3. Key Financials 19.4.15.4. SWOT Analysis 19.4.15.5. Key Developments 19.4.15.6. Sales Footprint 19.4.15.7. Strategy Overview 19.4.15.7.1. Marketing Strategy 19.4.15.7.2. Product Strategy 19.4.15.7.3. Channel Strategy 19.4.16. Argon Medical Devices Inc. 19.4.16.1. Overview 19.4.16.2. Product Portfolio 19.4.16.3. Key Financials 19.4.16.4. SWOT Analysis 19.4.16.5. Key Developments 19.4.16.6. Sales Footprint 19.4.16.7. Strategy Overview 19.4.16.7.1. Marketing Strategy 19.4.16.7.2. Product Strategy 19.4.16.7.3. Channel Strategy 19.4.17. BD (Becton, Dickinson and Company) 19.4.17.1. Overview 19.4.17.2. Product Portfolio 19.4.17.3. Key Financials 19.4.17.4. SWOT Analysis 19.4.17.5. Key Developments 19.4.17.6. Sales Footprint 19.4.17.7. Strategy Overview 19.4.17.7.1. Marketing Strategy 19.4.17.7.2. Product Strategy 19.4.17.7.3. Channel Strategy 19.4.18. Cardinal Health Inc. 19.4.18.1. Overview 19.4.18.2. Product Portfolio 19.4.18.3. Key Financials 19.4.18.4. SWOT Analysis 19.4.18.5. Key Developments 19.4.18.6. Sales Footprint 19.4.18.7. Strategy Overview 19.4.18.7.1. Marketing Strategy 19.4.18.7.2. Product Strategy 19.4.18.7.3. Channel Strategy 19.4.19. Teleflex Medical OEM 19.4.19.1. Overview 19.4.19.2. Product Portfolio 19.4.19.3. Key Financials 19.4.19.4. SWOT Analysis 19.4.19.5. Key Developments 19.4.19.6. Sales Footprint 19.4.19.7. Strategy Overview 19.4.19.7.1. Marketing Strategy 19.4.19.7.2. Product Strategy 19.4.19.7.3. Channel Strategy 19.4.20. ConMed Corporation 19.4.20.1. Overview 19.4.20.2. Product Portfolio 19.4.20.3. Key Financials 19.4.20.4. SWOT Analysis 19.4.20.5. Key Developments 19.4.20.6. Sales Footprint 19.4.20.7. Strategy Overview 19.4.20.7.1. Marketing Strategy 19.4.20.7.2. Product Strategy 19.4.20.7.3. Channel Strategy 19.4.21. Mindray Medical International Limited 19.4.21.1. Overview 19.4.21.2. Product Portfolio 19.4.21.3. Key Financials 19.4.21.4. SWOT Analysis 19.4.21.5. Key Developments 19.4.21.6. Sales Footprint 19.4.21.7. Strategy Overview 19.4.21.7.1. Marketing Strategy 19.4.21.7.2. Product Strategy 19.4.21.7.3. Channel Strategy 19.4.22. Hologic Inc. 19.4.22.1. Overview 19.4.22.2. Product Portfolio 19.4.22.3. Key Financials 19.4.22.4. SWOT Analysis 19.4.22.5. Key Developments 19.4.22.6. Sales Footprint 19.4.22.7. Strategy Overview 19.4.22.7.1. Marketing Strategy 19.4.22.7.2. Product Strategy 19.4.22.7.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Steerable Needle Market
